X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/17/2864586/0/en/ABVC-BioPharma-Executes-a-Global-Licensing-Definitive-Agreement-for-the-Treatment-of-NSCLC-Expecting-Aggregate-Income-of-13-75M-and-Royalties-of-up-to-12-50M.html
https://www.globenewswire.com/news-release/2024/04/10/2860744/0/en/ABVC-BioPharma-Executes-a-Global-Licensing-Term-Sheet-for-Oncology-Hematology-Products-Expecting-Licensing-Income-of-55M-and-Royalties-of-up-to-50M.html
https://endpts.com/skye-bioscience-uplists-oncoxs-licensing-deal-with-abvc-biopharma/
https://www.globenewswire.com/news-release/2024/03/26/2852346/0/en/ABVC-BioPharma-Entered-into-a-Global-Licensing-Deal-of-Vitargus-with-Licensing-Income-of-33-5M-and-Royalties-up-to-60M.html
https://www.globenewswire.com/news-release/2024/03/21/2850234/0/en/AiBtl-BioPharma-Inc-Completes-7-6M-Land-Deal-Exchanging-Stock-for-Real-Estate-Demonstrating-the-Value-of-ABVC-s-23M-AiBtl-Share-Ownership-as-Hundred-Million-Dollars.html
https://www.globenewswire.com/news-release/2024/03/19/2848565/0/en/ABVC-BioPharma-Inc-CEO-Selected-as-2024-Top-10-CEO-in-CEO-Insights-Asia-Magazine.html
https://www.globenewswire.com//news-release/2024/03/14/2846367/0/en/ABVC-BioPharma-Reports-Annual-2023-Financials-and-Provides-Fiscal-Year-2024-First-Quarter-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/27/2836048/0/en/ABVC-s-New-Horizon-for-Oncology-and-Hematology-Aims-at-Cancer-Market-of-Several-Hundred-Billion-Dollars.html
https://www.globenewswire.com//news-release/2024/02/15/2829968/0/en/ABVC-BioPharma-Executes-a-Definitive-Agreement-to-Receive-License-Fees-of-3M-and-Royalties-of-2-on-Future-Revenues.html
https://www.globenewswire.com//news-release/2024/02/12/2827532/0/en/ABVC-BioPharma-Receives-Australian-Patent-Valid-Until-2040-for-Its-Treatment-of-Major-Depressive-Disorder-MDD.html
Market Place
Share 
